Switch theme
Sign up to access all valuation multiples
Dexco SA is engaged in the production of wooden panels, vitreous chinaware, metal bathroom fittings and showers, and ceramic and cement floors. Its segments are: The Wood segment operates four industrial units in Brazil and three in Colombia producing MDP panels (medium density panels), MDF and HDF panels (medium and high fiber density panels), under the Duratex brand, the Durafloor brand for laminates and semi-finished components for furniture; The Deca segment operates in Brazil, producing vitreous chinaware, metal fittings, and showers, under the brands Deca, Hydra, Belize, Elizabeth, and Hydra Corona; the Ceramic Tile segment operates four industrial plants in Brazil, producing ceramic tiles, under the Ceusa, Portinari, and Castelatto brands; and Soluble Cellulose Segment.
1951
14.2K+
LTM Revenue $1.5B
LTM EBITDA $338M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dexco has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $338M.
In the most recent fiscal year, Dexco achieved revenue of $1.5B and an EBITDA of $290M.
Dexco expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dexco valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $513M | XXX | $451M | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $338M | XXX | $290M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $176M | XXX | $171M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $47.3M | XXX | $31.7M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $966M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Dexco's stock price is BRL 6 (or $1).
Dexco has current market cap of BRL 4.6B (or $847M), and EV of BRL 6.1B (or $1.1B).
See Dexco trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $847M | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Dexco has market cap of $847M and EV of $1.1B.
Dexco's trades at 0.7x EV/Revenue multiple, and 3.9x EV/EBITDA.
Equity research analysts estimate Dexco's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dexco has a P/E ratio of 17.9x.
See valuation multiples for Dexco and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $847M | XXX | $847M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 3.3x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBIT | 6.4x | XXX | 6.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 17.9x | XXX | 26.7x | XXX | XXX | XXX |
| EV/FCF | -20.1x | XXX | -96.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDexco's last 12 month revenue growth is 4%
Dexco's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $20K for the same period.
Dexco's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dexco's rule of X is 33% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dexco and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | -2% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 33% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $20K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| James Hardie | XXX | XXX | XXX | XXX | XXX | XXX |
| MATHIOS REFRACTORY | XXX | XXX | XXX | XXX | XXX | XXX |
| Cementos Argos | XXX | XXX | XXX | XXX | XXX | XXX |
| Grupo Argos | XXX | XXX | XXX | XXX | XXX | XXX |
| Ambuja Cements | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dexco acquired XXX companies to date.
Last acquisition by Dexco was XXXXXXXX, XXXXX XXXXX XXXXXX . Dexco acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Dexco founded? | Dexco was founded in 1951. |
| Where is Dexco headquartered? | Dexco is headquartered in Brazil. |
| How many employees does Dexco have? | As of today, Dexco has 14.2K+ employees. |
| Is Dexco publicy listed? | Yes, Dexco is a public company listed on BVMF. |
| What is the stock symbol of Dexco? | Dexco trades under DXCO3 ticker. |
| When did Dexco go public? | Dexco went public in 2009. |
| Who are competitors of Dexco? | Similar companies to Dexco include e.g. James Hardie, MATHIOS REFRACTORY, Cementos Argos, Grupo Argos. |
| What is the current market cap of Dexco? | Dexco's current market cap is $847M |
| What is the current revenue of Dexco? | Dexco's last 12 months revenue is $1.5B. |
| What is the current revenue growth of Dexco? | Dexco revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Dexco? | Current revenue multiple of Dexco is 0.7x. |
| Is Dexco profitable? | Yes, Dexco is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dexco? | Dexco's last 12 months EBITDA is $338M. |
| What is Dexco's EBITDA margin? | Dexco's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Dexco? | Current EBITDA multiple of Dexco is 3.3x. |
| What is the current FCF of Dexco? | Dexco's last 12 months FCF is -$56.4M. |
| What is Dexco's FCF margin? | Dexco's last 12 months FCF margin is -4%. |
| What is the current EV/FCF multiple of Dexco? | Current FCF multiple of Dexco is -20.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
